Who are Conjugated equine estrogen topical cream's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/conjugated-equine-estrogen-topical-cream.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Conjugated equine estrogen topical cream — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Conjugated equine estrogen topical cream (Conjugated equine estrogen topical cream) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical hormone replacement therapy; estrogen. Area: Gynecology; Menopause.

marketed Topical hormone replacement therapy; estrogen Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) Gynecology; Menopause Small molecule Live · refreshed every 30 min

Target snapshot

Conjugated equine estrogen topical cream (Conjugated equine estrogen topical cream) — University of Louisville. Conjugated equine estrogen topical cream delivers estrogen directly to vaginal and vulvar tissues to relieve menopausal symptoms such as vaginal atrophy and dryness.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Conjugated equine estrogen topical cream TARGET	Conjugated equine estrogen topical cream	University of Louisville	marketed	Topical hormone replacement therapy; estrogen	Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical hormone replacement therapy; estrogen class)

University of Louisville · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Conjugated equine estrogen topical cream — Competitive Intelligence Brief. https://druglandscape.com/ci/conjugated-equine-estrogen-topical-cream. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab